MBX Biosciences Cash Flow Statement (2023-2026) | MBX

Cash Flow Statement Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter) -10.16M-8.84M-12.34M-15.86M-18.14M-15.59M-23.88M-19.41M-21.62M-22.06M-23.52M
Depreciation and Depletion (Quarter) 0.10M0.04M0.05M0.10M0.10M0.04M0.08M0.10M0.10M0.05M0.06M
Share-based Compensation (Quarter) 0.23M1.02M1.62M0.33M0.53M1.49M1.84M0.77M1.32M2.66M5.48M
Gains from Sales and Divestitures (Quarter) 0.00M
Gains from Investment Securities (Quarter) 0.14M0.16M0.20M0.20M0.86M0.03M4.34M0.19M2.85M11.44M
Non-cash Items (Quarter) 4.54M63.13M34.31M2.38M12.93M22.30M97.75M2.28M
Cash from Operations (Quarter) -11.15M-10.71M-13.27M-14.66M-16.04M-22.68M-17.43M-21.54M-18.30M-20.21M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter) 0.60M0.50M0.44M0.59M1.40M1.34M0.98M0.73M0.56M0.58M
Depreciation & Amortization (CF) (Quarter) 0.10M0.04M0.05M0.10M0.10M0.04M0.08M0.10M0.10M0.05M0.06M
Change in Working Capital
Change in Account Payables (Quarter) -0.31M0.47M0.58M2.23M0.65M-1.56M2.01M-2.04M-0.86M3.97M
Change in Accured Expenses (Quarter) -1.18M-0.41M2.64M1.15M-0.20M0.56M-0.25M2.04M4.45M-4.86M
Investing Activities
Capital Expenditures (Quarter) 0.02M0.03M0.04M-0.05M0.86M0.50M0.23M0.40M0.79M0.44M
Change in Acquisitions & Divestments (Quarter) 5.00M24.25M8.25M27.00M20.25M57.15M73.12M61.35M76.25M57.50M
Cash from Investing Activities (Quarter) -28.95M15.43M-7.89M-100.79M-67.34M3.23M25.99M17.06M-129.97M-97.10M
Financing Activities
Other financing activities (Quarter) 0.01M1.81M1.92M0.33M0.25M0.52M0.38M
Change in Capital Stock
Shares Issued (Quarter) 0.74M0.19M0.05M-0.03M0.20M0.00M1.33M-1.33M2.44M
Preferred Shares Issued (Quarter) 68.51M
Misc.
Cash from Financing Activities (Quarter) 0.02M0.18M-1.76M235.81M-0.13M0.00M1.33M187.82M0.44M87.44M
Change in Cash (Quarter) -40.08M4.90M-22.92M120.36M-83.51M-19.45M9.88M183.34M-147.84M-29.87M
Free Cash Flow (Quarter) -11.16M-10.74M-13.31M-14.61M-16.89M-23.18M-17.67M-21.93M-19.09M-20.64M
Net Cash Flow (Quarter) -40.08M4.90M-22.92M120.36M-83.51M-19.45M9.88M183.34M-147.84M-29.87M